Improvement by eicosanoids in cancer cachexia induced by LLC-IL6 transplantation

Journal of Cancer Research and Clinical Oncology
T OhiraN Saijo

Abstract

Cachexia frequently occurs in the late stages of cancer, and is difficult to manage. We previously reported that interleukin-6 (IL-6) cDNA transfection into Lewis lung carcinoma (LLC-IL6) induced cachexia-like symptoms in C57BL/6 mice. This was thought to be a useful experimental model of cancer cachexia. We have examined the effects of two eicosanoids, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), in order to evaluate whether they could relieve cachexia. LLC-IL6-bearing animals were divided into three treatment groups receiving DHA, EPA or water as the control; 80-microliter samples of these compounds (purity > 95%) were administered orally by catheter daily starting 7 days after tumor transplantation. Tumor growth curves were similar in the three groups. There were no differences in water or food intake in the three groups. However, body weight, a marker of cachexia, was significantly higher in treated mice than in the control group. Sixteen days after tumor transplantation, the mean body weight was 17.45 g (P < 0.05), 17.2 g and 16.41 g in the groups receiving DHA, EPA and water respectively. The eicosanoids did not affect serum levels of IL-6. Ubiquitination of muscle protein, a marker of proteolysis coupled t...Continue Reading

References

Oct 1, 1990·Japanese Journal of Cancer Research : Gann·M KitaharaM Okada
Nov 15, 1990·International Journal of Cancer. Journal International Du Cancer·C LönnrothK Lundholm
Mar 1, 1990·The Journal of Experimental Medicine·J J MuléS A Rosenberg
Apr 1, 1990·The Journal of Clinical Investigation·R J HillJ Levin
Jun 1, 1989·The Journal of Experimental Medicine·P BrouckaertW Fiers
May 1, 1988·JPEN. Journal of Parenteral and Enteral Nutrition·K A Kern, J A Norton
Aug 1, 1984·Journal of the National Cancer Institute·R A KarmaliC Fuchs
Jun 30, 1984·Lancet·M JeevanandamM F Brennan

❮ Previous
Next ❯

Citations

Jul 3, 1998·Critical Reviews in Oncology/hematology·W G JiangD F Horrobin
Feb 2, 2000·Proceedings of the Society for Experimental Biology and Medicine·B E BartonT Murphy
Nov 24, 1999·Current Opinion in Clinical Nutrition and Metabolic Care·M J Tisdale
Jan 20, 2009·The Journal of Nutrition, Health & Aging·J E MorleyW J Evans
Mar 5, 2016·Chemical & Pharmaceutical Bulletin·Donggen PiaoJong-Keun Son
Aug 1, 2015·Cancer Metastasis Reviews·Seyed Fazel NabaviSeyed Mohammad Nabavi
Nov 6, 2002·Nutrition and Cancer·C Murray Ardies
Mar 25, 2006·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Rafat SiddiquiGary P Zaloga
Aug 13, 1999·The American Journal of Physiology·D D LazarusP J Elliott

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Related Papers

Duodecim; lääketieteellinen aikakauskirja
Olavi Ukkola
Nursing Standard
Sheila Nelsons
Cancer Nursing
M T Oberst
The British Journal of Surgery
R I WesdorpM F von Meyenfeldt
© 2021 Meta ULC. All rights reserved